866-997-4948(US-Canada Toll Free)

United States Insulin (API & Injection) Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

In this report, the United States Insulin (API & Injection) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.



Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Insulin (API & Injection) in these regions, from 2012 to 2022 (forecast).



United States Insulin (API & Injection) market competition by top manufacturers/players, with Insulin (API & Injection) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Novo Nordisk

Eli Lilly

Sanofi-Aventis

Dongbao

Bioton

United Laboratories

Merck

Ganlee



On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Animal Insulin

Human Insulin

Insulin Analogue

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Insulin (API & Injection) for each application, including

Diabetes

Coronary Heart Disease

Perioperation Period

Others



If you have any special requirements, please let us know and we will offer you the report as you want.



Table of Contents

United States Insulin (API & Injection) Market Report 2017
1 Insulin (API & Injection) Overview
1.1 Product Overview and Scope of Insulin (API & Injection)
1.2 Classification of Insulin (API & Injection) by Product Category
1.2.1 United States Insulin (API & Injection) Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Insulin (API & Injection) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Animal Insulin
1.2.4 Human Insulin
1.2.5 Insulin Analogue
1.3 United States Insulin (API & Injection) Market by Application/End Users
1.3.1 United States Insulin (API & Injection) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Diabetes
1.3.3 Coronary Heart Disease
1.3.4 Perioperation Period
1.3.5 Others
1.4 United States Insulin (API & Injection) Market by Region
1.4.1 United States Insulin (API & Injection) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Insulin (API & Injection) Status and Prospect (2012-2022)
1.4.3 Southwest Insulin (API & Injection) Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Insulin (API & Injection) Status and Prospect (2012-2022)
1.4.5 New England Insulin (API & Injection) Status and Prospect (2012-2022)
1.4.6 The South Insulin (API & Injection) Status and Prospect (2012-2022)
1.4.7 The Midwest Insulin (API & Injection) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Insulin (API & Injection) (2012-2022)
1.5.1 United States Insulin (API & Injection) Sales and Growth Rate (2012-2022)
1.5.2 United States Insulin (API & Injection) Revenue and Growth Rate (2012-2022)

2 United States Insulin (API & Injection) Market Competition by Players/Suppliers
2.1 United States Insulin (API & Injection) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Insulin (API & Injection) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Insulin (API & Injection) Average Price by Players/Suppliers (2012-2017)
2.4 United States Insulin (API & Injection) Market Competitive Situation and Trends
2.4.1 United States Insulin (API & Injection) Market Concentration Rate
2.4.2 United States Insulin (API & Injection) Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Insulin (API & Injection) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Insulin (API & Injection) Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Insulin (API & Injection) Sales and Market Share by Region (2012-2017)
3.2 United States Insulin (API & Injection) Revenue and Market Share by Region (2012-2017)
3.3 United States Insulin (API & Injection) Price by Region (2012-2017)

4 United States Insulin (API & Injection) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Insulin (API & Injection) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Insulin (API & Injection) Revenue and Market Share by Type (2012-2017)
4.3 United States Insulin (API & Injection) Price by Type (2012-2017)
4.4 United States Insulin (API & Injection) Sales Growth Rate by Type (2012-2017)

5 United States Insulin (API & Injection) Sales (Volume) by Application (2012-2017)
5.1 United States Insulin (API & Injection) Sales and Market Share by Application (2012-2017)
5.2 United States Insulin (API & Injection) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Insulin (API & Injection) Players/Suppliers Profiles and Sales Data
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insulin (API & Injection) Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Eli Lilly
6.2.2 Insulin (API & Injection) Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Eli Lilly Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
6.3.2 Insulin (API & Injection) Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi-Aventis Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Dongbao
6.4.2 Insulin (API & Injection) Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Dongbao Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bioton
6.5.2 Insulin (API & Injection) Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bioton Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 United Laboratories
6.6.2 Insulin (API & Injection) Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 United Laboratories Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Insulin (API & Injection) Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Ganlee
6.8.2 Insulin (API & Injection) Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Ganlee Insulin (API & Injection) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Insulin (API & Injection) Manufacturing Cost Analysis
7.1 Insulin (API & Injection) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin (API & Injection)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Insulin (API & Injection) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin (API & Injection) Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Insulin (API & Injection) Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Insulin (API & Injection) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Insulin (API & Injection) Sales Volume Forecast by Type (2017-2022)
11.3 United States Insulin (API & Injection) Sales Volume Forecast by Application (2017-2022)
11.4 United States Insulin (API & Injection) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Insulin (API & Injection)
Figure United States Insulin (API & Injection) Market Size (MT) by Type (2012-2022)
Figure United States Insulin (API & Injection) Sales Volume Market Share by Type (Product Category) in 2016
Figure Animal Insulin Product Picture
Figure Human Insulin Product Picture
Figure Insulin Analogue Product Picture
Figure United States Insulin (API & Injection) Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Insulin (API & Injection) by Application in 2016
Figure Diabetes Examples
Figure Coronary Heart Disease Examples
Figure Perioperation Period Examples
Figure Others Examples
Figure United States Insulin (API & Injection) Market Size (Million USD) by Region (2012-2022)
Figure The West Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insulin (API & Injection) Sales (MT) and Growth Rate (2012-2022)
Figure United States Insulin (API & Injection) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insulin (API & Injection) Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Insulin (API & Injection) Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Insulin (API & Injection) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insulin (API & Injection) Sales Share by Players/Suppliers
Figure 2017 United States Insulin (API & Injection) Sales Share by Players/Suppliers
Figure United States Insulin (API & Injection) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Insulin (API & Injection) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Insulin (API & Injection) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insulin (API & Injection) Revenue Share by Players/Suppliers
Figure 2017 United States Insulin (API & Injection) Revenue Share by Players/Suppliers
Table United States Market Insulin (API & Injection) Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Insulin (API & Injection) Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Insulin (API & Injection) Market Share of Top 3 Players/Suppliers
Figure United States Insulin (API & Injection) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Insulin (API & Injection) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Insulin (API & Injection) Product Category
Table United States Insulin (API & Injection) Sales (MT) by Region (2012-2017)
Table United States Insulin (API & Injection) Sales Share by Region (2012-2017)
Figure United States Insulin (API & Injection) Sales Share by Region (2012-2017)
Figure United States Insulin (API & Injection) Sales Market Share by Region in 2016
Table United States Insulin (API & Injection) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Insulin (API & Injection) Revenue Share by Region (2012-2017)
Figure United States Insulin (API & Injection) Revenue Market Share by Region (2012-2017)
Figure United States Insulin (API & Injection) Revenue Market Share by Region in 2016
Table United States Insulin (API & Injection) Price (USD/Kg) by Region (2012-2017)
Table United States Insulin (API & Injection) Sales (MT) by Type (2012-2017)
Table United States Insulin (API & Injection) Sales Share by Type (2012-2017)
Figure United States Insulin (API & Injection) Sales Share by Type (2012-2017)
Figure United States Insulin (API & Injection) Sales Market Share by Type in 2016
Table United States Insulin (API & Injection) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Insulin (API & Injection) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insulin (API & Injection) by Type (2012-2017)
Figure Revenue Market Share of Insulin (API & Injection) by Type in 2016
Table United States Insulin (API & Injection) Price (USD/Kg) by Types (2012-2017)
Figure United States Insulin (API & Injection) Sales Growth Rate by Type (2012-2017)
Table United States Insulin (API & Injection) Sales (MT) by Application (2012-2017)
Table United States Insulin (API & Injection) Sales Market Share by Application (2012-2017)
Figure United States Insulin (API & Injection) Sales Market Share by Application (2012-2017)
Figure United States Insulin (API & Injection) Sales Market Share by Application in 2016
Table United States Insulin (API & Injection) Sales Growth Rate by Application (2012-2017)
Figure United States Insulin (API & Injection) Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novo Nordisk Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Novo Nordisk Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Eli Lilly Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Eli Lilly Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Dongbao Basic Information List
Table Dongbao Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dongbao Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Dongbao Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Dongbao Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Bioton Basic Information List
Table Bioton Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bioton Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Bioton Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Bioton Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table United Laboratories Basic Information List
Table United Laboratories Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure United Laboratories Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure United Laboratories Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure United Laboratories Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Merck Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Merck Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Ganlee Basic Information List
Table Ganlee Insulin (API & Injection) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ganlee Insulin (API & Injection) Sales Growth Rate (2012-2017)
Figure Ganlee Insulin (API & Injection) Sales Market Share in United States (2012-2017)
Figure Ganlee Insulin (API & Injection) Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin (API & Injection)
Figure Manufacturing Process Analysis of Insulin (API & Injection)
Figure Insulin (API & Injection) Industrial Chain Analysis
Table Raw Materials Sources of Insulin (API & Injection) Major Players/Suppliers in 2016
Table Major Buyers of Insulin (API & Injection)
Table Distributors/Traders List
Figure United States Insulin (API & Injection) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Insulin (API & Injection) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Insulin (API & Injection) Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Insulin (API & Injection) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume (MT) Forecast by Type in 2022
Table United States Insulin (API & Injection) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume (MT) Forecast by Application in 2022
Table United States Insulin (API & Injection) Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Insulin (API & Injection) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insulin (API & Injection) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *